Clinical trial
Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)
NCT00148902 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00148902 |
|---|---|
| Title | Effects Of GW572016 In Combination With Docetaxel (TAXOTERE) |
| Official title | A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of GW572016 in Combination With Docetaxel (Taxotere) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms, Breast |
| Intervention type | Drug |
| Interventions | lapatinib, docetaxel |
| Enrollment | 52 |
| Start date | Apr 28, 2003 |
| Primary completion | Jan 21, 2006 |
| Completion | Jan 21, 2006 |
| First posted | Sep 8, 2005 |
| Last update posted | Dec 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: